Fatty Liver Disease

Fatty liver disease, medically known as hepatic lipidosis or hepatic steatosis, is a serious metabolic condition affecting small mammals in which excessive fat accumulates within liver cells, progressively impairing liver function. This condition represents one of the most common liver disorders in captive small mammals, reflecting the prevalence of dietary mismanagement and obesity in these pets. The liver plays crucial roles in metabolism, detoxification, protein synthesis, and numerous other vital functions, so fat accumulation that disrupts normal liver architecture can have far-reaching consequences throughout the body. In severe cases, fatty liver disease can progress to liver failure and death.

Fatty liver disease affects a wide range of small mammal species commonly kept as pets, though prevalence and underlying causes vary by species. Hamsters, particularly Syrian hamsters prone to obesity, commonly develop this condition when fed inappropriate diets high in fatty seeds and nuts. Hedgehogs are notoriously susceptible to obesity and subsequent fatty liver disease in captivity due to their propensity to overeat and restricted exercise opportunities. Sugar gliders develop hepatic lipidosis when fed high-fat diets lacking appropriate balance. Ferrets, chinchillas, rats, and gerbils can all develop fatty liver disease under certain dietary and metabolic circumstances.

The impact of fatty liver disease on small mammal health ranges from subclinical in early stages to devastating in advanced disease. Early accumulation of fat in liver cells may cause no apparent symptoms while silently compromising liver function. As fat accumulation progresses, the liver becomes enlarged and increasingly dysfunctional, leading to a cascade of metabolic derangements. Affected animals may show nonspecific signs such as lethargy, decreased appetite, and weight changes before more specific signs of liver disease become apparent. Advanced cases can develop jaundice, coagulopathies, hepatic encephalopathy, and ultimately liver failure.

Treatability of fatty liver disease depends largely on how early the condition is detected, the severity of liver damage at diagnosis, and whether underlying causes can be identified and corrected. Early-stage fatty liver disease is often reversible with appropriate dietary modification, weight management, and treatment of contributing conditions. However, advanced disease with significant liver cell death and fibrosis carries a guarded to poor prognosis. The insidious nature of this condition, combined with small mammals' tendency to hide illness, means many cases are not detected until significant damage has occurred. Awareness of risk factors and proactive management are essential for prevention. An exotic veterinarian experienced with small mammal medicine is crucial for accurate diagnosis and appropriate treatment of this complex metabolic condition.

Obesity stands as the primary cause of fatty liver disease in small mammals, creating a metabolic environment in which the liver accumulates fat faster than it can process and export it. When small mammals consistently consume more calories than they expend, excess energy is stored as fat throughout the body, including within liver cells. The sedentary lifestyles of many captive small mammals, combined with ad libitum access to high-calorie foods, create perfect conditions for obesity development. Over time, chronic fat accumulation in the liver overwhelms the organ's capacity to function normally, triggering a pathological cascade that becomes increasingly difficult to reverse.

Species-specific risk factors significantly influence fatty liver disease development. Hamsters have naturally high body fat percentages and readily become obese in captivity, particularly when provided unlimited access to seed-heavy diets. Syrian hamsters store fat in preparation for hibernation that never occurs in captivity, predisposing to obesity. Hedgehogs are notorious for obesity in captivity, with some studies suggesting over 50% of pet hedgehogs are overweight. Sugar gliders require carefully balanced diets, and those fed inappropriately high-fat foods develop fatty liver disease readily. Dwarf hamsters, especially Campbell's Russian dwarfs, have predisposition to diabetes which can contribute to hepatic lipidosis.

Dietary factors beyond simple overfeeding contribute significantly to fatty liver disease. Seed-based diets, while often marketed for small mammals, are typically too high in fat and low in essential nutrients, promoting both obesity and direct hepatic lipid accumulation. Excessive treats, particularly fatty nuts and human foods, compound dietary imbalances. Inadequate protein intake forces the liver to work harder while reducing its capacity to export fat. Diets deficient in lipotropic factors such as choline and methionine impair the liver's ability to process fat. Sudden food restriction in obese animals can paradoxically trigger acute hepatic lipidosis as the body rapidly mobilizes fat stores that overwhelm the liver.

Environmental and husbandry factors create conditions promoting fatty liver disease. Enclosures that are too small restrict normal activity and exercise. Lack of environmental enrichment reduces exploratory behavior and energy expenditure. Temperature extremes affect metabolism in ways that can promote fat accumulation. Chronic stress, while often causing weight loss in some contexts, can contribute to metabolic dysfunction and hepatic pathology in others. Social housing issues, including isolation in social species or overcrowding, create chronic stress affecting metabolism. Limited access to exercise equipment such as appropriately sized wheels further reduces activity levels.

The pathophysiology of fatty liver disease involves an imbalance between hepatic lipid input and output. Fat enters the liver from dietary absorption, mobilization from adipose tissue, and hepatic synthesis. Healthy livers export fat as very low-density lipoproteins for use by other tissues. When input exceeds output chronically, triglycerides accumulate within hepatocytes, causing cellular enlargement and dysfunction. Initially, this accumulation is reversible, but continued progression leads to hepatocyte death, inflammation, and eventually fibrosis or cirrhosis. The damaged liver loses its capacity for essential functions including protein synthesis, drug metabolism, bile production, and ammonia detoxification. Secondary metabolic derangements affect virtually every organ system as the liver's central role in metabolism becomes compromised.

Early warning signs of fatty liver disease in small mammals are often subtle and easily overlooked, contributing to the difficulty of early diagnosis. Behavioral changes may include slightly reduced activity levels, less interest in exploration or play, and increased time spent sleeping. Owners may notice their pet seems less enthusiastic about previously enjoyed activities or treats. Changes in appetite can go either direction, with some animals showing decreased interest in food while others continue eating normally or even excessively. Weight changes may be difficult to detect without regular weighing, though progressive obesity is often apparent visually. These early signs are nonspecific and commonly attributed to aging or other causes.

Visible physical symptoms become more apparent as fatty liver disease progresses. The abdomen may appear enlarged or distended due to hepatomegaly, though this can be difficult to distinguish from obesity in already overweight animals. Coat quality often deteriorates, becoming dull, dry, or unkempt as the liver's role in nutrient processing becomes impaired. Some animals develop a pot-bellied appearance distinct from generalized obesity. Gradual weight loss may occur as the disease advances, even if appetite is maintained, due to impaired nutrient metabolism. In light-colored animals, subtle yellowing of the skin or ears may indicate early jaundice.

Behavioral changes become more pronounced with advancing disease. Lethargy progresses from mild to marked, with affected animals spending most of their time inactive and showing reluctance to move. Appetite typically decreases significantly, and animals may become anorexic entirely. Decreased grooming results in an increasingly unkempt appearance. Social animals may withdraw from interaction with cage mates or owners. Nocturnal species may show altered sleep-wake cycles. Irritability or depression may develop. Some animals exhibit neurological changes including disorientation, circling, or apparent blindness, indicating hepatic encephalopathy from accumulating toxins the liver can no longer clear.

Physical examination findings in advancing disease become more dramatic. Palpable hepatomegaly, an enlarged liver that can be felt through the abdominal wall, becomes apparent in many cases, though small body size makes this assessment challenging. Jaundice, a yellowish discoloration of the skin, mucous membranes, and whites of the eyes due to accumulated bilirubin, indicates significant hepatic compromise. Ascites, fluid accumulation in the abdomen, can develop with advanced liver disease, causing abdominal distension distinct from hepatomegaly. Petechiae or ecchymoses, small hemorrhages visible under the skin or in mucous membranes, suggest coagulopathy from impaired clotting factor synthesis.

Symptom progression follows a variable timeline depending on the underlying cause and individual factors. Chronic fatty liver disease may develop over months to years before becoming clinically apparent, while acute hepatic lipidosis from sudden food restriction in obese animals can cause rapid deterioration within days. As liver function progressively fails, nonspecific signs give way to more specific indicators of hepatic disease. Neurological signs indicate advancing hepatic encephalopathy and carry poor prognosis. The terminal stages are marked by complete anorexia, severe weakness, hypothermia, and obtundation leading to coma and death.

Emergency symptoms requiring immediate veterinary intervention include severe jaundice, complete anorexia lasting more than 24 hours especially in an already ill animal, sudden collapse or extreme weakness, visible bleeding without apparent injury, severe neurological signs such as seizures or inability to stand, and marked abdominal distension. Any small mammal with known or suspected liver disease that suddenly worsens should be seen immediately. Because small mammals can deteriorate rapidly and hide illness effectively, owners should err on the side of seeking veterinary care promptly when any concerning signs are noted.

Diagnosis of fatty liver disease in small mammals requires a combination of clinical assessment, laboratory testing, and imaging studies, performed by an exotic veterinarian experienced with these species. The diagnostic process begins with thorough history taking, including detailed information about diet, feeding practices, weight trends, body condition over time, activity levels, housing conditions, and the nature and timeline of any symptoms. Physical examination assesses body condition score, abdominal palpation for hepatomegaly or fluid, mucous membrane color for jaundice, and neurological status. The veterinarian will also evaluate for signs of other conditions that may coexist with or cause fatty liver disease.

Laboratory diagnostics are essential for confirming liver disease and assessing its severity. Blood chemistry panels reveal elevations in liver enzymes including ALT, AST, and ALP that indicate hepatocellular damage or cholestasis. Bilirubin levels may be elevated, particularly with more advanced disease or bile duct involvement. Blood glucose may be abnormal due to the liver's role in glucose regulation. Serum proteins, particularly albumin, may be decreased due to impaired hepatic synthesis. Coagulation testing may reveal prolonged clotting times. Complete blood count can identify concurrent conditions. In small mammals, limited blood volume makes comprehensive testing challenging, and laboratories experienced with exotic species are needed for accurate results on small samples.

Imaging studies provide valuable information about liver structure and size. Radiographs can reveal hepatomegaly, altered liver margins, or concurrent conditions affecting other abdominal organs. Ultrasonography offers more detailed evaluation of liver texture and architecture, potentially revealing the characteristic increased echogenicity of fatty liver. Advanced imaging such as CT may be available at specialty practices and provides even greater detail. Imaging also allows evaluation of other organs that may be affected by liver disease or contributing to the condition. The small size of many small mammals makes imaging interpretation challenging and requires experienced operators and readers.

Definitive diagnosis of fatty liver disease requires histopathological examination of liver tissue, typically obtained through liver biopsy or at necropsy. Fine needle aspirates can provide cytological evidence of hepatic lipidosis but may not fully characterize disease severity or concurrent conditions. True biopsy samples allow assessment of fat accumulation, inflammation, fibrosis, and other pathological changes. However, biopsy procedures carry anesthetic and surgical risks in small, potentially debilitated patients, so the decision to pursue histopathology must weigh diagnostic value against procedure risks. In many cases, a presumptive diagnosis based on clinical findings, laboratory results, and imaging is sufficient to guide treatment.

Differential diagnosis for symptoms suggesting fatty liver disease includes other hepatic pathologies such as hepatitis, hepatic neoplasia, and biliary disease. Systemic infections affecting the liver must be considered. Cardiac disease causing hepatic congestion can produce similar signs. Gastrointestinal disease with secondary hepatic effects should be ruled out. Pancreatic disease, given the close anatomical and functional relationship between liver and pancreas, may present similarly or coexist. Metabolic diseases such as diabetes, particularly relevant in dwarf hamsters, can cause or contribute to fatty liver disease. The veterinarian must consider the complete clinical picture to arrive at accurate diagnosis and appropriate treatment.

Treatment of fatty liver disease in small mammals focuses on addressing underlying causes, providing nutritional support, and managing complications while allowing the liver to recover. Emergency stabilization is necessary for severely compromised patients and may include fluid therapy to address dehydration and support circulation, warmth support for hypothermic animals, glucose supplementation for hypoglycemic patients, and treatment of hepatic encephalopathy if present. The exotic veterinarian will assess the patient's stability and determine what level of intervention is appropriate given the individual situation and prognosis.

Medical management centers on addressing the metabolic derangements underlying fatty liver disease. Nutritional support is paramount, as continued anorexia worsens hepatic lipidosis while the liver requires adequate nutrition to recover. For anorexic patients, syringe feeding of appropriate critical care formulas provides essential calories and nutrients. The feedings must be frequent enough to meet metabolic needs, typically every few hours in very small mammals. Hepatoprotective medications such as S-adenosylmethionine, milk thistle, and ursodeoxycholic acid may be prescribed to support liver function and recovery, though evidence for efficacy in small mammals is largely extrapolated from other species.

Dietary modification is essential for long-term management and recovery from fatty liver disease. The diet should be transitioned to a balanced, species-appropriate formulation with controlled fat and calorie content while providing adequate protein and essential nutrients. Seed-heavy diets must be replaced with nutritionally complete pelleted foods appropriate for the species. Fresh vegetables appropriate for the species should be offered for fiber and micronutrients. Treats should be limited or eliminated during recovery. The transition must be gradual to avoid gastrointestinal upset and ensure continued food intake. A veterinary nutritionist consultation may be valuable for complex cases.

Supportive care encompasses multiple aspects of intensive management during recovery. Fluid therapy, administered subcutaneously for most outpatients or intravenously in hospitalized patients, maintains hydration and supports circulation. Environmental temperature should be maintained in the appropriate range for the species, with supplemental warmth provided for debilitated animals. Stress reduction through quiet housing, minimal handling, and appropriate cage setup supports immune function and recovery. Hepatic encephalopathy, if present, requires additional specific treatment including lactulose to reduce ammonia absorption and potentially antibiotics to reduce ammonia-producing bacteria.

Species-specific treatment considerations affect management approaches. Hamsters with fatty liver disease often have concurrent conditions such as diabetes, particularly in dwarf species, requiring additional management. Hedgehogs are highly prone to concurrent conditions including cardiac disease and neoplasia that may complicate treatment. Sugar gliders require very specific dietary management and are prone to stress that complicates handling and treatment. Ferrets often have fatty liver secondary to other conditions such as insulinoma that must be addressed. Chinchillas and other small mammals each have unique considerations regarding drug metabolism, stress sensitivity, and dietary requirements.

Treatment challenges in small mammal fatty liver disease are substantial. The small body size of these patients makes medication dosing critical and drug administration challenging. Many small mammals resist oral medications, and the stress of repeated handling and forced feeding can worsen the condition. Limited blood volume restricts monitoring capabilities. The expense of intensive treatment relative to the initial cost of the pet creates difficult decisions for owners. Concurrent conditions common in affected animals complicate management. Despite appropriate treatment, advanced cases may not recover due to irreversible liver damage. Owners must understand the guarded prognosis and be prepared for possible treatment failure.

Recovery from fatty liver disease is possible if the condition is detected before irreversible liver damage occurs and underlying causes are addressed effectively. The recovery timeline varies considerably depending on disease severity at diagnosis, the specific cause, and how well the patient responds to treatment. Early-stage fatty liver disease detected incidentally or through routine screening may resolve over weeks to months with dietary correction alone. Moderate cases requiring medical intervention typically need several weeks to months of treatment before significant improvement is evident. Severe cases with substantial liver compromise may take months to stabilize, with some degree of permanent liver dysfunction possible.

Post-treatment care and monitoring requirements extend well beyond the acute treatment phase. Dietary modifications must be maintained long-term, as return to inappropriate feeding will cause recurrence. Regular weight monitoring ensures body condition is improving without excessive weight loss or regain of obesity. Periodic veterinary rechecks assess overall health and may include follow-up blood work to monitor liver enzyme levels. The frequency of monitoring depends on disease severity and response to treatment, with more severely affected animals requiring more frequent assessment. Owners must remain vigilant for signs of relapse or complications.

Prognosis factors include the severity of hepatic lipid accumulation and resulting liver damage at diagnosis, the presence and nature of underlying causes, how well the animal tolerates treatment, whether appropriate diet and husbandry changes can be implemented and maintained, and individual variation in response. Early-stage disease in otherwise healthy animals carries good prognosis with appropriate intervention. Advanced disease with established fibrosis, concurrent conditions, or complications such as hepatic encephalopathy carries guarded to poor prognosis. Young animals may recover more completely than geriatric patients. Species-specific factors also influence outcomes.

Long-term outlook for recovered patients depends on the extent of permanent liver damage and success in maintaining appropriate management. Animals that recover from mild to moderate fatty liver disease with minimal residual damage can have normal or near-normal life expectancy with appropriate ongoing care. Those with significant permanent liver compromise may have shortened lifespans and remain more susceptible to liver-related complications. All recovered patients require permanent dietary management to prevent recurrence. Regular veterinary monitoring, typically at least annually for stable patients, helps ensure continued health. Quality of life is generally good for recovered patients maintained on appropriate diets with proper husbandry.

Prevention of fatty liver disease in small mammals centers on maintaining appropriate weight and providing species-appropriate nutrition throughout the animal's life. The foundation of prevention is a balanced, species-appropriate diet fed in controlled amounts. Research the specific nutritional requirements of your species, as needs vary dramatically between hamsters, hedgehogs, sugar gliders, and other small mammals. Feed high-quality commercial diets formulated for your specific species rather than generic small animal mixes. Limit or avoid seed-based diets, which are typically too high in fat for sedentary captive animals. Measure food portions rather than providing unlimited access, and adjust amounts based on body condition.

Dietary prevention strategies extend beyond basic feeding practices. Treats should constitute only a small percentage of total diet, and healthy treat options should replace fatty nuts and seeds for most small mammal species. Fresh vegetables appropriate for the species add fiber and nutrients without excessive calories. Avoid human foods, especially those high in sugar or fat. Introduce any dietary changes gradually to prevent gastrointestinal upset and food refusal. Learn to assess your pet's body condition and adjust food amounts to maintain optimal weight. Weigh your pet regularly to detect gradual weight changes that might not be visually apparent.

Stress reduction supports metabolic health and reduces disease risk. Provide appropriately sized enclosures that allow natural behaviors and exercise. Include exercise equipment such as appropriately sized wheels for species that use them. Offer environmental enrichment through foraging opportunities, hiding places, and varied cage furniture. Maintain appropriate social housing for the species, whether that means solitary housing for Syrian hamsters or pairs/groups for social species. Keep enclosures in quiet locations with consistent light cycles. Handle gently and appropriately, allowing time for acclimation for new pets.

Regular health monitoring enables early detection when prevention measures fall short. Weigh your small mammal weekly or at minimum monthly, recording weights to track trends over time. Learn your pet's normal behavior and activity patterns so changes are apparent. Observe appetite, water consumption, and waste output daily. Perform periodic visual body condition assessments, noting any changes in shape or apparent weight. Watch for subtle signs of illness that might indicate underlying health issues.

Veterinary check-ups with an exotic-experienced veterinarian provide professional assessment and guidance. Establish care with an exotic veterinarian before problems arise, as not all veterinarians are trained in small mammal medicine. Schedule wellness examinations at least annually, more frequently for geriatric animals or those with health concerns. Discuss diet and nutrition during visits to ensure feeding practices are appropriate. Report any weight changes or concerning signs promptly. Consider baseline blood work in middle-aged to older animals to detect subclinical disease. Early detection and intervention provide the best opportunity for successful management of fatty liver disease if it develops.

Daily care requirements for small mammals with fatty liver disease or at risk for the condition focus on supporting liver health through meticulous attention to diet, weight management, and stress reduction. Food should be measured and provided in appropriate amounts based on veterinary guidance, with uneaten portions removed before adding fresh food. Fresh, clean water must be available at all times, with water bottles checked daily for proper function. The enclosure should be spot-cleaned daily, with complete bedding changes as appropriate for the species and setup. Daily observation of activity level, appetite, water consumption, and waste output helps detect changes that might indicate worsening condition.

Environmental management creates conditions supporting metabolic health and recovery. Temperature should be maintained within the appropriate range for the species, as both heat and cold stress affect metabolism. Humidity should be moderate and appropriate for the species. Lighting should follow consistent cycles approximating natural daylight patterns. The enclosure should be large enough to encourage activity and include species-appropriate exercise equipment. Environmental enrichment encourages natural behaviors and activity. Cleaning products should be pet-safe and thoroughly rinsed to avoid residues that could stress an already compromised liver.

Monitoring health indicators is essential for managing fatty liver disease and detecting changes early. Weight should be recorded weekly or more frequently during active treatment, using a gram scale for accurate measurement of small patients. Body condition should be assessed visually and by palpation, noting changes in apparent fat distribution. Appetite and food consumption should be tracked, noting any decreases that might herald worsening condition. Fecal output and character provide information about gastrointestinal function. Overall activity and behavior should be observed daily, with any changes noted. Maintaining a health journal helps identify trends and provides valuable information for veterinary visits.

Quality of life considerations guide management decisions for animals with liver disease. Assess whether your pet can engage in normal species-appropriate behaviors including eating, moving, grooming, and interacting with its environment. Consider whether treatment requirements cause stress that outweighs benefits. Evaluate appetite and apparent interest in food and activities. Note signs of pain or discomfort such as hunching, teeth grinding, or reluctance to move. Discuss quality of life assessment with your exotic veterinarian, who can help evaluate whether current management is appropriate or if modifications are needed. In cases of advanced, irreversible disease, humane euthanasia may be the kindest option.

Caregiver support and resources help owners navigate the challenges of managing small mammal liver disease. Connect with species-specific communities and forums where experienced owners share knowledge. Maintain open communication with your exotic veterinarian and don't hesitate to ask questions or express concerns. Understand that some cases will not respond to treatment despite best efforts, and this is not a failure on the owner's part. Budget for potential ongoing veterinary expenses and consider pet insurance or savings accounts for exotic pet medical care. Recognize the emotional impact of caring for a chronically ill pet and seek support when needed. Prioritize your pet's quality of life throughout the management process.

Hamsters of all species are predisposed to fatty liver disease due to their natural tendency to store fat for hibernation combined with the high-fat diets and limited activity typical of captivity. Syrian hamsters, the largest and most commonly kept species, readily become obese when fed ad libitum seed-based diets and are frequently diagnosed with hepatic lipidosis. Dwarf hamsters, including Campbell's Russian, Winter White Russian, and Roborovski hamsters, are also susceptible, with Campbell's hamsters additionally predisposed to diabetes that can contribute to fatty liver disease. Female hamsters may be at slightly higher risk due to metabolic differences. Hamsters over one year of age show increased prevalence as the cumulative effects of dietary mismanagement manifest.

Hedgehogs are notoriously prone to obesity and fatty liver disease in captivity, with some estimates suggesting more than half of pet hedgehogs are overweight. Their propensity to overeat when food is freely available, combined with limited exercise in typical captive settings, creates ideal conditions for hepatic lipidosis. African pygmy hedgehogs, the species commonly kept as pets, seem particularly susceptible. Middle-aged to older hedgehogs show highest disease prevalence as years of dietary mismanagement take their toll. Hedgehogs also have high rates of other conditions including cardiac disease and cancer that can coexist with or be exacerbated by fatty liver disease. The combination of obesity predisposition and multiple concurrent disease risks makes hedgehog liver disease particularly challenging.

Sugar gliders develop fatty liver disease when fed inappropriate high-fat diets lacking appropriate nutritional balance. These marsupials have complex nutritional requirements that are frequently not met in captivity, with diets high in fatty foods and inadequate in calcium being particularly problematic. Malnutrition may contribute to hepatic dysfunction even in animals that are not obese. Other species including ferrets, chinchillas, rats, and gerbils can also develop fatty liver disease under certain conditions, though prevalence varies. Ferrets may develop fatty liver secondary to other conditions such as insulinoma. Rats, while not as prone to primary fatty liver disease, can develop hepatic lipidosis under extreme dietary conditions. Recognition of species-specific risk factors allows targeted prevention strategies.

Fatty liver disease commonly occurs alongside or leads to other conditions that complicate management. Obesity is essentially always present or recently present in cases of hepatic lipidosis and must be addressed as part of treatment, though overly aggressive weight loss can worsen acute hepatic lipidosis. Diabetes mellitus, particularly relevant in dwarf hamsters, frequently coexists with fatty liver disease and shares overlapping causes including obesity and improper diet. Hyperlipidemia, elevated blood fat levels, both contributes to and results from fatty liver disease. Cardiac disease may develop secondary to metabolic dysfunction or may coexist independently, particularly in hedgehogs. Pancreatic disease given the anatomical and functional relationship with the liver may occur concurrently.

Several conditions present with symptoms similar to fatty liver disease and must be differentiated for appropriate treatment. Other liver diseases including hepatitis, hepatic neoplasia, biliary disease, and hepatic abscess can cause similar clinical signs. Gastrointestinal disease affecting nutrient absorption and metabolism may present with overlapping symptoms. Kidney disease causes metabolic derangements and may coexist with liver disease in systemically ill animals. Cardiac disease causing hepatic congestion produces signs of liver dysfunction. Systemic infections or sepsis can cause secondary liver damage. Careful diagnostic workup is needed to identify all conditions present and guide comprehensive treatment.

Secondary complications of fatty liver disease extend beyond hepatic dysfunction. Hepatic encephalopathy develops when the failing liver cannot clear ammonia and other toxins from the blood, causing neurological signs ranging from subtle behavior changes to seizures and coma. Coagulopathy results from impaired synthesis of clotting factors, predisposing to bleeding. Ascites develops when portal hypertension and reduced albumin production cause fluid accumulation in the abdomen. Hypoglycemia can occur due to impaired hepatic glucose regulation. Secondary infections may develop as immune function becomes compromised. Multiple organ dysfunction may develop in end-stage disease as the systemic effects of liver failure cascade through other organ systems.